Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohort

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 1-7

  Soldà, Francesca ^a   Lodge, Mark ^b   Ashley, Sue ^c   Whitington, Alastair ^d   Goldstraw, Peter ^e   Brada, Michael ^f  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^c Guy's Hospital ^*

^d GUY S HOSPITAL   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f Leaders in Oncology Care (LOC)   (United Kingdom)

Author keywords

Non small cell lung cancer; Stereotactic radiotherapy; Surgery

Indexed keywords

CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION;

NON-SMALL CELL LUNG CANCER; STEREOTACTIC RADIOTHERAPY; SURGERY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOSURGERY;

EID: 84888067377     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.09.006     Document Type: Article

References (59)

1. National Cancer Action Team. National Radiotherapy Implementation Group Report. Stereotactic body radiotherapy clinical review of the evidence for SBRT 2010. Available from: http://ncat.nhs.uk/sites/default/files/ clinical%20evidence%20review%20Dec%2010%20-%20Final%20J11.pdf.
2. P. Goldstraw, J. Crowley, and K. Chansky The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
3. M. Partridge, M. Ramos, A. Sardaro, and M. Brada Dose escalation for non-small cell lung cancer: analysis and modelling of published literature Radiother Oncol 99 2011 6 11
4. OCEBM Levels of Evidence Working Groupâ̂ -. The Oxford Levels of Evidence 2. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/ index.aspx?o=5653. â̂ -OCEBM Table of Evidence Working Group = Jeremy Howick, Iain Chalmers (James Lind Library), Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard and Mary Hodgkinson.
5. A. Takeda, E. Kunieda, N. Sanuki, Y. Aoki, Y. Oku, and H. Handa Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer Lung Cancer 77 2012 77 82
6. A. van Baardwijk, W.A. Tomé, and W. van Elmpt Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review Radiother Oncol 105 2012 145 149
7. J. Widder, T.J. Klinkenberg, J.F. Ubbels, E.M. Wiegman, H.J.M. Groen, and J.A. Langendijk Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? Radiother Oncol 107 2013 409 413
8. K. Clarke, M. Taremi, and M. Dahele Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome? Radiother Oncol 104 2012 62 66
9. M. Ayadi, C. Ginestet, F. Gassa, L. Claude, and J.J. Mazeron Linac-based stereotactic radiosurgery and radiotherapy Bull Cancer 97 2010 791 806
10. G.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control Int J Radiat Oncol Biol Phys 77 2010 344 349
11. J. Brock, J. Bedford, and M. Partridge Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy-a planning study Clin Oncol (R Coll Radiol) 24 2012 68 75
12. M. Marcenaro, S. Vagge, and L. Belgioia Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor Anticancer Res 33 2013 655 660
13. J.J. Nuyttens, and M. van de Pol The CyberKnife radiosurgery system for lung cancer Expert Rev Med Devices 9 2012 465 475
14. N. Andratschke, F. Zimmermann, and E. Boehm Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure Radiother Oncol 101 2011 245 249
15. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795
16. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
17. J.J. Beitler, E.A. Badine, and D. El-Sayah Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years Int J Radiat Oncol Biol Phys 65 2006 100 106
18. J.E. Bibault, B. Prevost, E. Dansin, X. Mirabel, T. Lacornerie, and E. Lartigau Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer Radiat Oncol 7 2012 102
19. S. Bral, T. Gevaert, and N. Linthout Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial Int J Radiat Oncol Biol Phys 80 2011 1343 1349
20. W.T. Brown, X. Wu, and F. Fayad Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent Clin Oncol (R Coll Radiol) 21 2009 623 631
21. E. Champeaux-Orange, T. Wachter, H. Bouscayrol, and I. Barillot Stereotactic radiotherapy for stage I and II lung cancer: a study of 33 patients Cancer Radiother 15 2011 192 196
22. Y. Chen, W. Guo, Y. Lu, and B. Zou Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy Radiother Oncol 88 2008 351 358
23. D. Coon, A.S. Gokhale, S.A. Burton, D.E. Heron, C. Ozhasoglu, and N. Christie Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning Clin Lung Cancer 9 2008 217 221
24. N.E. Dunlap, J.M. Larner, and P.W. Read Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) J Thorac Cardiovasc Surg 140 2010 583 589
25. T. Dworzecki, A. Idasiak, D. Sygula, U. Dworzecka, and R. Suwinski Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients Neoplasma 59 2012 114 120
26. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
27. P. Fritz, H.J. Kraus, and T. Blaschke Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning Lung Cancer 60 2008 193 199
28. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
29. M. Guckenberger, J. Wulf, and G. Mueller Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation Int J Radiat Oncol Biol Phys 74 2009 47 54
30. Y. Hamamoto, M. Kataoka, and M. Yamashita Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors Jpn J Radiol 30 2012 430 434
31. H. Hof, M. Muenter, D. Oetzel, A. Hoess, J. Debus, and K. Herfarth Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC) Cancer 110 2007 148 155
32. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Hoyer Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
33. M. Koto, Y. Takai, and Y. Ogawa A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer Radiother Oncol 85 2007 429 434
34. Q.T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
35. Y. Matsuo, K. Shibuya, and Y. Nagata Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1104 1111
36. S.K. Nath, A.P. Sandhu, and L. Jensen Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/computed tomography Clin Lung Cancer 12 2011 180 186
37. A.W. Ng, S.Y. Tung, and V.Y. Wong Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs Radiother Oncol 87 2008 24 28
38. J.R. Olsen, C.G. Robinson, and I. El Naqa Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 303
39. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
40. H. Onishi, H. Shirato, and Y. Nagata Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
41. B. Parashar, P. Patel, and S. Monni Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer Cancer 116 2010 5047 5053
42. O.M. Salazar, T.S. Sandhu, and P.B. Lattin Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers Int J Radiat Oncol Biol Phys 72 2008 707 715
43. M. Scorsetti, P. Navarria, and A. Facoetti Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer Anticancer Res 27 2007 3615 3619
44. S. Senthi, F.J. Lagerwaard, C.J. Haasbeek, B.J. Slotman, and S. Senan Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
45. Y. Shibamoto, C. Hashizume, and F. Baba Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study Cancer 118 2012 2078 2084
46. S.Y. Song, W. Choi, and S.S. Shin Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus Lung Cancer 66 2009 89 93
47. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland clinic experience J Thorac Oncol 4 2009 976 982
48. A. Takeda, N. Sanuki, and E. Kunieda Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm Int J Radiat Oncol Biol Phys 73 2009 442 448
49. M. Taremi, A. Hope, and M. Dahele Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients Int J Radiat Oncol Biol Phys 82 2012 967 973
50. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
51. N. Trakul, C.N. Chang, and J. Harris Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors Int J Radiat Oncol Biol Phys 84 2012 231 237
52. M. Turzer, O.T. Brustugun, E. Waldeland, and A. Helland Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity Case Rep Oncol 4 2011 25 34
53. S. Vahdat, E.K. Oermann, and S.P. Collins CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment J Hematol Oncol 3 2010 6
54. N.C. van der Voort van Zyp, B. van der Holt, R.J. van Klaveren, P. Pattynama, A. Maat, and J.J. Nuyttens Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer Lung Cancer 69 2010 296 301
55. J. Widder, D. Postmus, J.F. Ubbels, E.M. Wiegman, and J.A. Langendijk Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer Int J Radiat Oncol Biol Phys 81 2011 e291 297
56. D. Wu, H. Zhu, H. Tang, C. Li, and F. Xu Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma Radiat Oncol 6 2011 84
57. T. Xia, H. Li, and Q. Sun Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 117 125
58. Y. Hamamoto, M. Kataoka, and M. Yamashita Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer Jpn J Clin Oncol 40 2010 125 129
59. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839